Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

ECOR vs HSDT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HSDT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 8–1 Matrix Metrics)

HSDT Overall Winner 6-Pillar Tally: ECOR 2 – 3 HSDT (1 Tie) Matrix Metrics: ECOR 1 – 8 HSDT

As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECOR carries a Unified Composite Score of 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin), whereas HSDT carries 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin).

  • Technical & Structure Timing Caution: ECOR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5); meanwhile HSDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ECOR vs HSDT
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
TTM Revenue $38M
Forward P/E N/M
Beta / 30D Vol 1.52β · 155% Vol
Unified Composite Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 32
RSI-14: 31.5 · SMA20: $6.90 · SMA50: $8.67
HSDT NASDAQ Head-to-Head Winner
Solana Company Class A Common Stock (DE)
Electromedical & Electrotherapeutic Apparatus
$1.66
+1.84% 1D
Market Cap $103.1M
TTM Revenue $272M
Forward P/E N/M
Beta / 30D Vol 2.20β · 55% Vol
Unified Composite Score
59.0 / 100 HOLD
Tech 60.0 Fund 53.0 Flow 58.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 29
RSI-14: 29.4 · SMA20: $1.96 · SMA50: $2.31

6-Pillar Scorecard Institutional Category Breakdown (ECOR 2 – 3 HSDT)

Columns: Metric · ECOR · HSDT
1. Valuation Multiples HSDT
Forward P/E N/M N/M
Trailing P/E N/M 0.0x
PEG Ratio N/M N/M
EV / Revenue 1.4x 0.4x
2. Growth & Scale HSDT
Revenue Growth (YoY) +11.5% +382.1%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $38M $272M
Market Cap $47.7M $103.1M
3. Profitability & Quality HSDT
Gross Margin 87.7% 92.8%
Operating Margin -33.1% -1557.5%
Net Profit Margin -33.5% 2040.4%
Return on Equity (ROE) -478.7% 52.8%
4. Balance Sheet & Cash Flow ECOR
Cash Generation (TTM) -$6.9M -$4.22B EBITDA
Cash Flow Margin -18.1% N/A
Net Cash / Leverage $4.6M Net Debt $4.38 Book/Sh · 52.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ECOR
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 540.7% (85th %ile)
Put/Call OI Skew N/A 7.50x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Medical Devices Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ECOR (1) vs HSDT (8)
Institutional Metric ECOR HSDT Criterion Row Edge
Market Capitalization
Scale
$47.7M $103.1M Larger Scale HSDT
Trailing P/E Ratio
Valuation
N/M 0.0x Lower Multiple HSDT
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+11.5% +382.1% Higher Growth HSDT
Operating Margin (TTM)
Profitability
-33.1% -1557.5% Higher Margin ECOR
Net Profit Margin
Profitability
-33.5% 2040.4% Higher Margin HSDT
Return on Equity (ROE)
Capital Efficiency
-478.7% 52.8% Higher ROE HSDT
52-Week Range Position
Momentum
6% ($4–$13) 15% ($1–$4) Stronger Trend HSDT
Beta / 30D Volatility
Risk Regime
1.52β · 155% Vol 2.20β · 55% Vol Lower Realized Risk HSDT
Unified Institutional Score
Composite Signal
56.8 / 100 (HOLD) 59.0 / 100 (HOLD) Higher Composite HSDT
Trailing 12M Revenue (USD)
Operating Scale
$38M $272M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
87.7% 92.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.4x EV/Rev N/M PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$6.9M ($4.6M Net Debt) -$4.22B EBITDA ($4.38 Book/Sh · 52.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HSDT +4.35 pp
ECOR: -34.01% · HSDT: -29.66%
3M Horizon HSDT +32.95 pp
ECOR: -53.9% · HSDT: -20.95%
6M Horizon ECOR +10.63 pp
ECOR: -19.03% · HSDT: -29.66%
1Y Horizon ECOR +54.54 pp
ECOR: -3.96% · HSDT: -58.5%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ECOR Revenue HSDT Revenue ECOR Op. Margin HSDT Op. Margin Margin Leader
FY2018 $0M $0M -5494.1% -5580.5% ECOR
FY2019 $0M $0M -1928.2% -1604.0% HSDT
FY2020 $0M $0M -707.9% -2176.4% ECOR
FY2021 $10M $0M -367.7% -3679.9% ECOR
FY2022 $10M $0M -266.2% -1994.3% ECOR
FY2023 $20M $0M -120.2% -2054.2% ECOR
FY2024 $30M $0M -48.3% -2673.7% ECOR
FY2025 $30M $0M -41.1% -44496.4% ECOR

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ECOR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ECOR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HSDT BREAKDOWN
42d in phase · OBV DISTRIBUTION
Current IV 540.7%
IV Percentile 85th %ile
Put/Call OI Skew 7.50x (Put-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact HSDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ECOR Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $47.7M market capitalization and -33.1% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HSDT Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $103.1M market capitalization and -1557.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ECOR vs HSDT Key Questions & Quantitative Answers

As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECOR carries a Unified Composite Score of 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin), whereas HSDT carries 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin). Technical & Structure Timing Caution: ECOR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5); meanwhile HSDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HSDT leads the Growth & Scale pillar: ECOR posts +11.5% YoY revenue growth and +0.0% YoY earnings growth on $38M TTM revenue (87.7% gross margin, -33.1% operating margin), compared with HSDT at +382.1% YoY revenue growth and +0.0% YoY earnings growth on $272M TTM revenue (92.8% gross margin, -1557.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ECOR cumulative revenue shifted +200.0% while HSDT shifted N/A. In operating R&D and SG&A reinvestment, ECOR deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HSDT.

HSDT screens cheaper on headline valuation multiples. ECOR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.4x EV/Revenue (-18.1% FCF margin), whereas HSDT trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECOR (-478.7% ROE) versus HSDT (52.8% ROE) capital efficiency.

In options market volatility and institutional positioning, ECOR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.52β · 155% Vol realized risk). By comparison, HSDT carries 540.7% implied volatility (85th %ile, Extreme (>80th %ile)), a 7.50x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.20β · 55% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.